Drug
Talazoparib
Talazoparib: highest development phase Phase 2, developed by BioMarin Pharmaceutical. 1 trial record tracked on RxWires.
- Highest phase
- Phase 2
- Developer
- BioMarin Pharmaceutical
Trials
| Drug | Phase | Indication |
|---|---|---|
| Talazoparib Tosylate NCT02401347 | Phase 2 | Advanced Breast Cancer |
Latest
No recent events.
Follow Talazoparib on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.